Biochemical Features and Clinical Factors Influencing Response to Surfactant Treatment Among Infants Born Late Preterm with Respiratory Distress Syndrome
- PMID: 40373953
- DOI: 10.1016/j.jpeds.2025.114644
Biochemical Features and Clinical Factors Influencing Response to Surfactant Treatment Among Infants Born Late Preterm with Respiratory Distress Syndrome
Abstract
Objective: To evaluate main biophysically active surfactant components and inflammatory mediators, and to identify the factors associated with good response to surfactant, in late preterm infants with respiratory distress syndrome (RDS).
Study design: This was a prospective, multicenter, cohort study enrolling late (gestational age 34+0/7-36+6/7 weeks [late-PTRDS]) and moderately (gestational age 32+0/7-33+6/7 weeks, [moderately-PTRDS]) preterm infants with RDS. Term infants with no lung disease (term-NLD) were enrolled as controls. The concentration of disaturated-phosphatidylcholine (DSPC), surfactant protein-B (SP-B), total proteins, interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in epithelial lining fluids were measured by high-performance liquid chromatography-mass spectrometry, enzyme-linked immunosorbent assay, Lowry, or Luminex techniques, respectively, and corrected using plasma-to-bronchoalveolar lavage fluid urea ratio. Clinical data, including inspired oxygen fraction (FiO2) and preductal oxygen hemoglobin saturation (SpO2), were recorded in real-time.
Results: We studied 55 late-PTRDS, 44 moderately-PTRDS, and 18 term-NLD infants. DSPC was lower in late-PTRDS (43 [24-124] mg/dL) than in term-NLD (249 [147-688] mg/dL, P < .001) but similar to that of moderately-PTRDS (30 [9-80] mg/dL, P = .083). SP-B, total proteins, IL-1β, IL-6, and tumor necrosis factor-α were similar between late-PTRDS and moderately-PTRDS. SP-B, total proteins, and IL-6 were significantly higher in late-PTRDS than term-NLD. Each hour of delay for surfactant administration, each 5-point increase in FiO2 threshold, and each 5-point decrease in preductal hemoglobin saturation SpO2/FiO2 ratio before surfactant treatment decreased the likelihood of good response by 12% (P = .002), 28% (P = .019) and 15% (P = .028), respectively.
Conclusions: Late-PTRDS had DSPC and SP-B levels similar to moderately-PTRDS. Early administration, lower FiO2 threshold, and better oxygenation prior to surfactant treatment were associated with a better response to surfactant therapy.
Keywords: bronchoalveolar lavage fluid; disaturated-phosphatidylcholine; late preterm; lung inflammation; response; surfactant.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest D.D.L. reports a relationship with Chiesi Farmaceutici SpA that includes: board membership, consulting or advisory, funding grants, nonfinancial support, and speaking and lecture fees. They also report a relationship with Airway therapeutics Inc. that includes: board membership and consulting or advisory. V.C. reports a relationship with Chiesi Pharmaceuticals Inc that includes: board membership, consulting or advisory, funding grants, nonfinancial support, and speaking and lecture fees. These companies produce surfactant or surfactant components but had no role whatsoever in the present work. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
